Supriya Lifescience Empowers Women in India's $5 Trillion Goal

Photo:Representative Image

In a landmark declaration aligning with International Women's Day, Supriya Lifescience Ltd., a distinguished global manufacturer of active pharmaceutical ingredients (APIs), has underscored the indispensable contribution of women to India's ambitious pursuit of a USD 5 trillion economy by 2027.

Supriya Lifescience has a well-established presence in API manufacturing, focusing on products of various therapeutic segments like – anti-histamines, anti-allergics, vitamins, anesthetics, anti-asthmatics, etc.

Director of Supriya Lifescience, Dr. Saloni Wagh, delivered a resounding tribute to women, portraying them as dynamic agents of change within India's economic landscape. Dr. Wagh emphasized that women are not passive observers but active catalysts across diverse sectors, from pharmaceutical and healthcare to technology, driving growth and fostering innovation.

"Today, as we commemorate International Women's Day, it's imperative to recognize the pivotal role of women in propelling our nation towards economic prosperity," remarked Dr. Wagh.

"Initiatives such as the Mudra Yojana and increased female enrollment in higher education serve as a testament to our unwavering commitment to female empowerment, vital for achieving our USD 5 trillion ambition," Dr. Wagh added.

Supriya Lifescience's dedication to gender equality and inclusive growth is deeply ingrained within its ethos, as highlighted by Dr. Wagh. Founded by Dr Satish Wagh, a visionary first-generation entrepreneur, the company's core values revolve around ethical practices and environmental health and safety standards, further reinforcing its commitment to societal progress.

Dr. Wagh's statement reflects the ethos of Supriya Lifescience and symbolizes a broader acknowledgment of women's indispensable role in driving economic advancement. As the company continues to lead in API manufacturing, it sets a powerful precedent for the pharmaceutical industry and beyond, championing the empowerment and recognition of women as fundamental pillars of economic success.

Established in 1987, Supriya Lifescience Ltd. is a leading global manufacturer of APIs. The US FDA, EDQM, EUGMP, NMPA, and Health Canada certified its state-of-the-art facility. The building is located at Khed in Ratnagiri district, and the head office is in Mumbai, India.